Cohort-profile: Household transmission of SARS-CoV-2 in a low-resource community in Rio de Janeiro, Brazil

• Published in: BMJ open Vol. 12; no. 12; p. e067212
• Main Authors: Brasil, Patrícia, Damasceno, Luana, Fuller, Trevon, Bastos, Leonardo S, Cruz, Oswaldo G, Medeiros, Fernando, Calvet, Guilherme Amaral, Resende, Paola, Whitworth, Jimmy, Smith, Chris, Siqueira, Marilda M, Carvalho, Marilia
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group 07-12-2022
• Series: Cohort profile
• Subjects: Adult; Antibodies; Brazil - epidemiology; Child; COVID-19 - epidemiology; Female; Humans; Infectious Diseases; Male; Pandemics - prevention & control; Prospective Studies; SARS-CoV-2; Brazil; COVID-19; Epidemiology; Community child health
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2022-067212

To better understand the household transmission of SARS-COV-2 in a low-resource community in Rio de Janeiro during the COVID-19 pandemic (2020-2022).
This is an open prospective cohort study of children ≤12 years old and their household contacts. During home visits over 24 months, we collected data on sociodemographic characteristics, behavioural data, clinical manifestations of SARS-CoV-2, vaccination status, SARS-CoV-2 (reverse transcription-polymerase chain reaction) RT-PCR and anti-S antibody tests. Among adults, the majority of participants were women (62%).
We enrolled 845 families from May 2020 to May 2022. The median number of residents per household was four. The median household density, defined as the number of persons per room, was 0.95. The risk of SARS-CoV-2 occurrence was higher in households with a high number of persons per room. Children were not the principal source of SARS-CoV-2 infections in their households during the first wave of the pandemic.
Future studies will investigate cellular and humoral immune responses to locally circulating SARS-CoV-2 variants, which is relevant for the design of vaccines, antivirals and monoclonal antibodies. We will also engage in outreach to encourage vaccination as a means of limiting the transmission of novel SARS-CoV-2 variants and other emerging pathogens.